Inicio › Carcinoma epitelial de ovario › Nueva York
Ensayos clínicos de Carcinoma epitelial de ovario en Nueva York
10 estudios sobre Carcinoma epitelial de ovario buscan participantes en Nueva York.
Ciudades en Nueva York
Texto oficial del estudio (inglés)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Imbert Cancer Center /ID# 275634, Bay Shore
- Northwell Health Cancer Institute At Huntington /ID# 276814, Greenlawn
- Northwell Health Center for Advanced Medicine. /ID# 275641, Lake Success
- y 2 más
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 29 sept 2026 · NCT06890338Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Mineola
- Avenzo Therapeutics Recruiting Site, New York
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT05867251A Study of Isoquercetin in People With Ovarian Cancer
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- y 1 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT07303894AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Research Site, The Bronx
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 21 jul 2026 · NCT07218809Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University, New York
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 2 jul 2026 · NCT06819007A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- y 1 más
Reclutando
Edades de 18 en adelante · Mujeres · Actualizado el 1 jul 2026 · NCT05429970A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Site 0173, New York
ReclutandoFase 1
Edades de 18 en adelante · Mujeres · Actualizado el 7 abr 2026 · NCT04516447A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 mar 2026 · NCT06395519A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
- Roswell Park Cancer Institute, Buffalo
ReclutandoFase 1
Edades de 18 en adelante · Mujeres · Actualizado el 3 feb 2026 · NCT06469281Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Memorial Sloan Kettering, New York
- Columbia University Herbert Irving Comprehensive Cancer Center, New York
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 ago 2025 · NCT04429542De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.